A. Alizadeh, M. Eisen, R. Davis, C. Ma, I. Lossos et al., Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling, Nature, vol.303, issue.6769, pp.503-511, 2000.
DOI : 10.1038/35000501

S. Aukema, R. Siebert, E. Schuuring, G. Van-imhoff, H. Kluin-nelemans et al., Double-hit B-cell lymphomas, Blood, vol.117, issue.8, pp.2319-2331, 2011.
DOI : 10.1182/blood-2010-09-297879

S. Barrans, S. Crouch, A. Smith, K. Turner, R. Owen et al., Is Associated With Poor Prognosis in Patients With Diffuse Large B-Cell Lymphoma Treated in the Era of Rituximab, Journal of Clinical Oncology, vol.28, issue.20, pp.3360-3365, 2010.
DOI : 10.1200/JCO.2009.26.3947

K. Basso, U. Klein, H. Niu, G. Stolovitzky, Y. Tu et al., Tracking CD40 signaling during germinal center development, Blood, vol.104, issue.13, pp.4088-4096, 2004.
DOI : 10.1182/blood-2003-12-4291

URL : http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.325.1378

K. Basso, A. Margolin, G. Stolovitzky, U. Klein, R. Dalla-favera et al., Reverse engineering of regulatory networks in human B cells, Nature Genetics, vol.14, issue.4, pp.382-390, 2005.
DOI : 10.1101/gad.906601

D. Calado, Y. Sasaki, S. Godinho, A. Pellerin, K. Kochert et al., The cell-cycle regulator c-Myc is essential for the formation and maintenance of germinal centers, Nature Immunology, vol.160, issue.11, pp.1092-1100, 2012.
DOI : 10.1016/j.immuni.2006.04.005

M. Callanan, L. Baccon, P. Mossuz, P. Duley, S. Bastard et al., The IgG Fc receptor, Fcgamma RIIB, is a target for deregulation by chromosomal translocation in malignant lymphoma, Proceedings of the National Academy of Sciences, vol.97, issue.1, pp.309-314, 2000.
DOI : 10.1073/pnas.97.1.309

G. Caraux and S. Pinloche, PermutMatrix: a graphical environment to arrange gene expression profiles in optimal linear order, Bioinformatics, vol.21, issue.7, pp.1280-1281, 2005.
DOI : 10.1093/bioinformatics/bti141

URL : https://hal.archives-ouvertes.fr/lirmm-00105307

M. Chao, A. Alizadeh, C. Tang, J. Myklebust, B. Varghese et al., Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma, Cell, vol.142, issue.5, pp.699-713, 2010.
DOI : 10.1016/j.cell.2010.07.044

B. Cheson and J. Leonard, Monoclonal Antibody Therapy for B-Cell Non-Hodgkin's Lymphoma, New England Journal of Medicine, vol.359, issue.6, pp.613-626, 2008.
DOI : 10.1056/NEJMra0708875

H. Choi, D. Ghosh, and A. Nesvizhskii, Statistical Validation of Peptide Identifications in Large-Scale Proteomics Using the Target-Decoy Database Search Strategy and Flexible Mixture Modeling, Journal of Proteome Research, vol.7, issue.1, pp.286-292, 2008.
DOI : 10.1021/pr7006818

M. Compagno, W. Lim, A. Grunn, S. Nandula, M. Brahmachary et al., Mutations of multiple genes cause deregulation of NF-??B in diffuse large B-cell lymphoma, Nature, vol.272, issue.7247, pp.717-721, 2009.
DOI : 10.1038/nature07968

W. Cuccuini, J. Briere, N. Mounier, H. Voelker, A. Rosenwald et al., MYC+ diffuse large B-cell lymphoma is not salvaged by classical R-ICE or R-DHAP followed by BEAM plus autologous stem cell transplantation, Blood, vol.119, issue.20, pp.4619-4624, 2012.
DOI : 10.1182/blood-2012-01-406033

URL : https://hal.archives-ouvertes.fr/inserm-00716894

J. Delmore, G. Issa, M. Lemieux, P. Rahl, J. Shi et al., BET Bromodomain Inhibition as??a Therapeutic Strategy to Target c-Myc, Cell, vol.146, issue.6, pp.904-917, 2011.
DOI : 10.1016/j.cell.2011.08.017

D. Dominguez-sola, G. Victora, C. Ying, R. Phan, M. Saito et al., The proto-oncogene MYC is required for selection in the germinal center and cyclic reentry, Nature Immunology, vol.8, issue.11, pp.1083-1091
DOI : 10.1084/jem.194.11.1625

D. Santos, A. Court, M. Thiers, V. Sar, S. Guettier et al., Identification of Cellular Targets in Human Intrahepatic Cholangiocarcinoma Using Laser Microdissection and Accurate Mass and Time Tag Proteomics, Molecular & Cellular Proteomics, vol.9, issue.9, pp.1991-2004, 2010.
DOI : 10.1074/mcp.M110.000026

URL : https://hal.archives-ouvertes.fr/inserm-00515623

V. Dupierris, C. Masselon, M. Court, S. Kieffer-jaquinod, and C. Bruley, A toolbox for validation of mass spectrometry peptides identification and generation of database: IRMa, Bioinformatics, vol.25, issue.15, pp.1980-1981, 2009.
DOI : 10.1093/bioinformatics/btp301

P. Filippakopoulos, J. Qi, S. Picaud, Y. Shen, W. Smith et al., Selective inhibition of BET bromodomains, Nature, vol.4, issue.7327, pp.1067-1073, 2010.
DOI : 10.1038/nature09504

C. French, Pathogenesis of NUT Midline Carcinoma, Annual Review of Pathology: Mechanisms of Disease, vol.7, issue.1, pp.247-265, 2012.
DOI : 10.1146/annurev-pathol-011811-132438

J. Friedberg, Relapsed/refractory diffuse large B-cell lymphoma. Hematol Am Soc Hematol Educ Program, pp.498-505, 2011.
DOI : 10.1182/asheducation-2011.1.498

D. Gancz, N. Donin, and Z. Fishelson, Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death, Molecular Immunology, vol.47, issue.2-3, pp.310-317, 2009.
DOI : 10.1016/j.molimm.2009.09.016

A. Gilchrist, C. Au, J. Hiding, A. Bell, J. Fernandez-rodriguez et al., Quantitative Proteomics Analysis of the Secretory Pathway, Cell, vol.127, issue.6, pp.1265-1281, 2006.
DOI : 10.1016/j.cell.2006.10.036

G. Gokul, G. Ramakrishna, and S. Khosla, overexpression mimics carcinogenesis, Epigenetics, vol.4, issue.5, pp.322-329, 2009.
DOI : 10.4161/epi.4.5.9239

J. Govin, C. Caron, E. Escoffier, M. Ferro, L. Kuhn et al., Post-meiotic Shifts in HSPA2/HSP70.2 Chaperone Activity during Mouse Spermatogenesis, Journal of Biological Chemistry, vol.281, issue.49, pp.37888-37892, 2006.
DOI : 10.1074/jbc.M608147200

Z. Hao, G. Duncan, J. Seagal, Y. Su, C. Hong et al., Fas Receptor Expression in Germinal-Center B Cells Is Essential for T and B Lymphocyte Homeostasis, Immunity, vol.29, issue.4, pp.615-627, 2008.
DOI : 10.1016/j.immuni.2008.07.016

M. Hummel, S. Bentink, H. Berger, W. Klapper, S. Wessendorf et al., A Biologic Definition of Burkitt's Lymphoma from Transcriptional and Genomic Profiling, New England Journal of Medicine, vol.354, issue.23, pp.2419-2430, 2006.
DOI : 10.1056/NEJMoa055351

A. Janic, L. Mendizabal, S. Llamazares, D. Rossell, and C. Gonzalez, Ectopic Expression of Germline Genes Drives Malignant Brain Tumor Growth in Drosophila, Science, vol.330, issue.6012, pp.1824-1827, 2010.
DOI : 10.1126/science.1195481

A. Jazirehi, M. Vega, and B. Bonavida, Development of Rituximab-Resistant Lymphoma Clones with Altered Cell Signaling and Cross-Resistance to Chemotherapy, Cancer Research, vol.67, issue.3, pp.1270-1281, 2007.
DOI : 10.1158/0008-5472.CAN-06-2184

B. Jeon, W. Choi, M. Yu, A. Yoon, M. Kim et al., ZBTB2, a Novel Master Regulator of the p53 Pathway, Journal of Biological Chemistry, vol.284, issue.27, pp.17935-17946, 2009.
DOI : 10.1074/jbc.M809559200

Z. Jin, V. Josserand, J. Razkin, E. Garanger, D. Boturyn et al., Noninvasive optical imaging of ovarian metastases using Cy5- labeled RAFT-c(-RGDfK-)4, Mol Imag, vol.5, pp.188-197, 2006.

N. Johnson, K. Savage, O. Ludkovski, S. Ben-neriah, R. Woods et al., Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival, Blood, vol.114, issue.11, pp.2273-2279, 2009.
DOI : 10.1182/blood-2009-03-212191

A. Kapoor, M. Goldberg, L. Cumberland, K. Ratnakumar, M. Segura et al., The histone variant macroH2A suppresses melanoma progression through regulation of CDK8, Nature, vol.4, issue.7327, pp.1105-1109, 2010.
DOI : 10.1038/nature09590

A. Karnowski, S. Chevrier, G. Belz, A. Mount, D. Emslie et al., B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1, The Journal of Experimental Medicine, vol.156, issue.11, pp.2049-2064, 2012.
DOI : 10.1126/science.277.5323.221

M. Kato, M. Sanada, I. Kato, Y. Sato, J. Takita et al., Frequent inactivation of A20 through gene mutation in B-cell lymphomas, Rinsho Ketsueki, vol.52, pp.313-319, 2009.

U. Keller, J. Huber, J. Nilsson, M. Fallahi, M. Hall et al., Myc suppression of Nfkb2 accelerates lymphomagenesis, BMC Cancer, vol.20, issue.14, p.348, 2010.
DOI : 10.1038/sj.onc.1204245

A. Lajmanovich, J. Ribeyron, A. Florin, A. Fournier, M. Pasquier et al., Identification, characterisation and regulation by CD40 activation of novel CD95 splice variants in CD95-apoptosis-resistant, human, B-cell non-Hodgkin's lymphoma, Experimental Cell Research, vol.315, issue.19, pp.3281-3293, 2009.
DOI : 10.1016/j.yexcr.2009.09.008

L. Baccon, P. Leroux, D. Dascalescu, C. Duley, S. Marais et al., Novel evidence of a role for chromosome 1 pericentric heterochromatin in the pathogenesis of B-cell lymphoma and multiple myeloma, Genes, Chromosomes and Cancer, vol.111, issue.3, pp.250-264, 2001.
DOI : 10.1002/gcc.1189

G. Lenz, G. Wright, S. Dave, X. W. Powell, J. Zhao et al., Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2323, 2008.
DOI : 10.1056/NEJMoa0802885

C. Levy, C. Frecha, C. Costa, N. Rachinel, G. Salles et al., Lentiviral vectors and transduction of human cancer B cells, Blood, vol.116, issue.3, pp.498-500, 2010.
DOI : 10.1182/blood-2010-03-276014

URL : https://hal.archives-ouvertes.fr/ensl-00817036

R. Lindsley and A. Lacasce, Biology of double-hit B-cell lymphomas, Current Opinion in Hematology, vol.19, issue.4, pp.299-304, 2012.
DOI : 10.1097/MOH.0b013e328353bbbd

J. Lohr, P. Stojanov, M. Lawrence, D. Auclair, B. Chapuy et al., Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing, Proceedings of the National Academy of Sciences, vol.109, issue.10, pp.3879-3884, 2012.
DOI : 10.1073/pnas.1121343109

C. Love, Z. Sun, D. Jima, G. Li, J. Zhang et al., The genetic landscape of mutations in Burkitt lymphoma, Nature Genetics, vol.57, issue.12, pp.1321-1325, 2012.
DOI : 10.1126/science.1145720

J. Mertz, A. Conery, B. Bryant, P. Sandy, S. Balasubramanian et al., Targeting MYC dependence in cancer by inhibiting BET bromodomains, Proceedings of the National Academy of Sciences, vol.108, issue.40, pp.16669-16674, 2011.
DOI : 10.1073/pnas.1108190108

A. Michallet, L. Lebras, and B. Coiffier, Maintenance therapy in diffuse large B-cell lymphoma, Current Opinion in Oncology, vol.24, issue.5, pp.461-465, 2012.
DOI : 10.1097/CCO.0b013e3283562036

V. Ngo, R. Young, R. Schmitz, S. Jhavar, X. W. Lim et al., Oncogenically active MYD88 mutations in human lymphoma, Nature, vol.206, issue.7332, pp.115-119, 2011.
DOI : 10.1038/nature09671

C. Ott, N. Kopp, L. Bird, R. Paranal, J. Qi et al., BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia, Blood, vol.120, issue.14, pp.2843-2852, 2012.
DOI : 10.1182/blood-2012-02-413021

L. Pasqualucci, The genetic basis of diffuse large B-cell lymphoma, Current Opinion in Hematology, vol.20, issue.4, pp.336-344, 2013.
DOI : 10.1097/MOH.0b013e3283623d7f

N. Reynoird, B. Schwartz, M. Delvecchio, K. Sadoul, D. Meyers et al., Oncogenesis by Research Article www.embomolmed.org CYCLON?induced Rituximab resistance ß 2013 The Authors, EMBO Mol Med, vol.5, pp.1180-1195, 2010.

S. Rousseaux and S. Khochbin, New hypotheses for large-scale epigenome alterations in somatic cancer cells: a role for male germ-cell-specific regulators, Epigenomics, vol.1, issue.1, pp.153-161, 2009.
DOI : 10.2217/epi.09.1

S. Rousseaux, A. Debernardi, B. Jacquiau, A. Vitte, A. Vesin et al., Ectopic Activation of Germline and Placental Genes Identifies Aggressive Metastasis-Prone Lung Cancers, Science Translational Medicine, vol.5, issue.186, pp.186-66, 2013.
DOI : 10.1126/scitranslmed.3005723

URL : https://hal.archives-ouvertes.fr/hal-01261754

S. Fleur, S. Hoshino, A. Kondo, K. Egawa, T. Fujii et al., Regulation of Fas-mediated immune homeostasis by an activation-induced protein, Cyclon, Blood, vol.114, issue.7, pp.1355-1365, 2009.
DOI : 10.1182/blood-2008-11-189118

K. Savage, N. Johnson, S. Ben-neriah, J. Connors, L. Sehn et al., MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy, Blood, vol.114, issue.17, pp.3533-3537, 2009.
DOI : 10.1182/blood-2009-05-220095

I. Schlosser, M. Holzel, R. Hoffmann, H. Burtscher, F. Kohlhuber et al., Dissection of transcriptional programmes in response to serum and c-Myc in a human B-cell line, Oncogene, vol.24, issue.3, pp.520-524, 2005.
DOI : 10.1038/sj.onc.1208198

J. Sporn, G. Kustatscher, T. Hothorn, M. Collado, M. Serrano et al., Histone macroH2A isoforms predict the risk of lung cancer recurrence, Oncogene, vol.28, issue.38, pp.3423-3428, 2009.
DOI : 10.1136/jcp.2005.031351

A. Su, T. Wiltshire, S. Batalov, H. Lapp, K. Ching et al., A gene atlas of the mouse and human protein-encoding transcriptomes, Proceedings of the National Academy of Sciences, vol.101, issue.16, pp.6062-6067, 2004.
DOI : 10.1073/pnas.0400782101

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-15550, 2005.
DOI : 10.1073/pnas.0506580102

S. Swerdlow, E. Campo, N. Harris, E. Jaffe, S. Pileri et al., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Rituximab-mediated cell signaling and chemo/ immuno-sensitization of drug-resistant B-NHL is independent of its Fc functions, International Agency for Research, pp.6582-6594, 2008.

J. Vert, N. Foveau, C. Lajaunie, and Y. Vandenbrouck, An accurate and interpretable model for siRNA efficacy prediction, BMC Bioinformatics, vol.7, issue.1, p.520, 2006.
DOI : 10.1186/1471-2105-7-520

URL : https://hal.archives-ouvertes.fr/hal-00433579

C. Visco, A. Tzankov, Z. Xu-monette, R. Miranda, Y. Tai et al., Patients with diffuse large B-cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study, Haematologica, vol.98, issue.2, pp.255-263, 2013.
DOI : 10.3324/haematol.2012.066209

J. Wang, A. Emadali, L. Bescont, A. Callanan, M. Rousseaux et al., Induced malignant genome reprogramming in somatic cells by testis-specific factors, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, vol.1809, issue.4-6, pp.221-225, 2011.
DOI : 10.1016/j.bbagrm.2011.04.003

P. Wilker, M. Kohyama, M. Sandau, J. Albring, O. Nakagawa et al., Transcription factor Mef2c is required for B cell proliferation and survival after antigen receptor stimulation, Nature Immunology, vol.173, issue.6, pp.603-612, 2008.
DOI : 10.1038/35040593

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2518613

F. Zhan, Y. Huang, S. Colla, J. Stewart, I. Hanamura et al., The molecular classification of multiple myeloma, Blood, vol.108, issue.6, pp.2020-2028, 2006.
DOI : 10.1182/blood-2005-11-013458

J. Zhang, V. Grubor, C. Love, A. Banerjee, K. Richards et al., Genetic heterogeneity of diffuse large B-cell lymphoma, Proceedings of the National Academy of Sciences, vol.110, issue.4, pp.1398-1403, 2013.
DOI : 10.1073/pnas.1205299110

A. Zippo, D. Robertis, A. Serafini, R. Oliviero, and S. , PIM1-dependent phosphorylation of histone H3 at serine 10 is required for MYC-dependent transcriptional activation and oncogenic transformation, Nature Cell Biology, vol.375, issue.8, pp.932-944, 2007.
DOI : 10.1038/sj.emboj.7600516

J. Zuber, J. Shi, E. Wang, A. Rappaport, H. Herrmann et al., RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia, Nature, vol.41, issue.7370, pp.524-528, 2011.
DOI : 10.1038/nature10334